.. PUBLIC Collections

[If article https://tradinglessons.beehiiv.com/p/the-easy-money-is-gone disappears, it was archived -- https://archive.ph/LG5pP]

This is what everyone saw on Monday 2026-06-22

→ Wednesday: -5%. → Thursday: -3.6%. → Markets closed Friday for Juneteenth. → Monday: -16.4%.

SpaceX closed at $154.60 — its biggest one-day decline since going public and a sharp reversal from last week's peak near $225.

The Calendar.
Insiders can sell up to 44% of SpaceX by early September. The float could grow 900%.

22V Research strategist Jeff Jacobson laid out the actual lockup schedule — and once you see it, the last three days make a lot more sense.

Today only about 4.2% of SpaceX shares are freely tradeable.

That scarcity helped fuel the IPO rally.

The problem is that scarcity doesn't last forever.

That means up to 44% of shares could become eligible for sale by early September.

For context: Today's float is approximately 4.2%.

The available share supply could increase by roughly 900%.

tells you that

• Your tags show up as filters — each tag you use becomes a clickable filter. There’s also a Without tags filter to find bookmarks that have no tags yet. ​ but does not include filter notags:true

Why do "#" tags work in my own overall collectio, but in my Public collection have to use tags:xxx

Gemini summary of Cytonics You are likely referring to the biotech company Cytonics, which operates outside the traditional venture capital model. It is a private company developing a potential disease-modifying therapy for osteoarthritis (CYT-108). Because it has not gone public, Cytonics stock cannot be bought directly on Robinhood.How to Invest in CytonicsEquity Crowdfunding: Cytonics has bypassed traditional Wall Street, choosing instead to raise millions of dollars from thousands of everyday retail investors. You can view their ongoing or past funding rounds and invest directly on the Cytonics Investment Platform.Secondary Markets: Since Cytonics is a private entity, pre-IPO investments may occasionally be accessible to accredited investors through secondary marketplaces like Forge Global.Caution: Investing in pre-IPO or clinical-stage biotech startups is highly speculative and illiquid; there is a risk of losing your entire investment.What is Cytonics?Core Science: Cytonics is focused on developing therapeutics based on Alpha-2-Macroglobulin (A2M), a natural blood protein that fights cartilage breakdown.Current Status: They have completed Phase 1 FDA trials for their lead drug candidate, CYT-108, and are preparing for Phase 2 studies to prove it can reverse and cure osteoarthritis.

Cytonics [-- https://www.facebook.com/Cytonics/posts/most-biotech-companies-are-built-for-venture-capital-before-theyre-built-for-pat/1632847908846010/ --]Cytonics' cyt-108, a recombinant protein for osteoarthritis ...Jun 16, 2026 — Cytonics took a different path. CYT-108 isn't a synthetic compound the industry invented and tried to force into a broken pathway.Facebook·Cytonics [-- https://www.gritt.io/investor/njp0020/ --]Investor Profile - Gritt.ioCytonics is a research and development company dedicated to discovering and developing therapeutics based on the protease inhibito...www.gritt.io [-- https://invest.cytonics.com/ --]Invest in Cytonics | The First Drug to Potentially Cure ...Jun 15, 2026 — Cytonics took a different approach. Cytonics is developing the first potential disease-modifying therapy for osteoarthritis. CYT-1...Cytonics Corporation [-- https://www.startengine.com/offering/cytonics --]Invest in Cytonics | StartEngineOur mission is to rid the world of the pain, suffering, and debilitated quality of life caused by Osteoarthritis (OA). Cytonics is...StartEngine [-- https://cytonics.com/investors/ --]Investors - Cytonics CorporationCorporate Overview. Cytonics is a clinical-stage biotechnology company developing CYT‑108, a genetically engineered variant of Alp...Cytonics Corporation [-- https://cytonics.com/57-%F0%9F%91%8E-why-cytonics-turned-down-vc/ --]57: 👎 Why Cytonics Turned Down VCNo VC. No Strings. No Compromise. Venture Capital is the kiss of death for biotech. They swoop in with fat checks, then slowly str...Cytonics Corporation [-- https://forgeglobal.com/cytonics_ipo/ --]Cytonics IPO: Investment Opportunities & Pre-IPO ValuationsJan 22, 2025 — To invest in Cytonics pre-IPO. Can you invest in Cytonics pre-IPO? Cytonics is privately held and not traded on public markets, so...Forge Global [-- https://www.prnewswire.com/news-releases/cytonics-announces-launch-of-regulation-a-equity-crowdfunding-campaign-to-fund-phase-2-development-302408233.html --]Cytonics Announces Launch of Regulation A+ Equity ...Mar 25, 2025 — Share this article. Share toX. Cytonics Seeks $24 million to pursue FDA Phase 2 Clinical Study of CYT-108, the Company's Novel The...PR Newswire [-- https://forgeglobal.com/cytonics_stock/ --]Invest and Sell Cytonics Stock - Forge GlobalJan 22, 2025 — * Is Cytonics a public company? No, Cytonics is a privately held company and is currently not publicly traded on any stock markets...Forge Global [-- https://forgeglobal.com/cytonics_stock/ --]Invest and Sell Cytonics Stock - Forge GlobalJan 22, 2025 — * Is Cytonics a public company? No, Cytonics is a privately held company and is currently not publicly traded on any stock markets...Forge Global AI responses may include mistakes. For financial advice, consult a professional. Learn more [-- https://support.google.com/websearch?p=ai_overviews&hl=en --]